Kanada - Englisch - Health Canada

sandoz canada incorporated - timolol (timolol maleate) - solution (extended release) - 0.25% - timolol (timolol maleate) 0.25% - beta-adrenergic agents

Kanada - Englisch - Health Canada

sandoz canada incorporated - timolol (timolol maleate) - solution (extended release) - 0.5% - timolol (timolol maleate) 0.5% - beta-adrenergic agents

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

apotex nz ltd - timolol maleate 3.4 mg/ml equivalent to 2.5mg/ml timolol - eye drops, solution - 0.25 % - active: timolol maleate 3.4 mg/ml equivalent to 2.5mg/ml timolol excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate sodium hydroxide water for injection - apo-timop is indicated for the reduction of elevated intraocular pressure. in clinical trials timolol maleate has been shown to reduce intraocular pressure in: - patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma - some patients with secondary glaucoma - patients with narrow angles and a history of spontaneous or iatrogenically induced narrow-angle closure in the opposite eye in whom reduction of intraocular pressure is necessary apo-timop is also indicated as concommitant therapy in patients with paediatric glaucoma who are inadequately controlled with other antiglaucoma therapy

Malta - Englisch - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - timolol - eye drops, solution - timolol 5 mg/ml - ophthalmologicals

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; water for injections; dibasic sodium phosphate; hydrochloric acid; sodium chloride; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

akorn - timolol (unii: 817w3c6175) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 2.56 mg in 1 ml - betimol® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. betimol® is contraindicated in patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, or severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - timolol maleate 6.84 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - 0.5 % - active: timolol maleate 6.84 mg/ml equivalent to 5 mg/ml timolol excipient: benzododecinium bromide gelrite mannitol trometamol water for injection

Irland - Englisch - HPRA (Health Products Regulatory Authority)

santen oy - timolol base - eye drops, solution - 0.25 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

santen oy - timolol base - eye drops, solution - 0.5 percent weight/volume - beta blocking agents1); timolol - it is a beta-adrenoreceptor blocking agent used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate dodecahydrate; sodium chloride; monobasic sodium phosphate dihydrate; purified water; benzalkonium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.